Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Expected to Rise, Guggenheim Analyst Says
Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) had its price target hoisted by Guggenheim from $78.00 to $84.00 in a research note published on Friday,Benzinga reports. They currently have a buy rating on the stock. A number of other equities research analysts have also recently issued reports on TARS. Oppenheimer upped their price objective on shares […]
Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) had its price target hoisted by Guggenheim from $78.00 to $84.00 in a research note published on Friday,Benzinga reports. They currently have a buy rating on the stock. A number of other equities research analysts have also recently issued reports on TARS. Oppenheimer upped their price objective on shares […]
